These factors could provide a scientific basis for consistency evaluations of the quality and efficacy of insulin biosimilars, study authors wrote. Factors that may affect the bioequivalence of test ...

Some people with diabetes require insulin. They can manually administer this through several methods, such as syringes, which are available in different sizes with various-sized needles. There are ...

Two long-acting insulin analogs have been developed for use as "basal" components of insulin treatment regimens: glargine and detemir. (Insulin glargine has US Food and Drug Administration [FDA] ...

section 1. Basic principles -- section 2. Dietary treatment of diabetes -- section 3. Treatment with insulin preparations -- section 4. Complications of diabetes -- section 5. Preparations of iletin ...

The global insulin delivery devices market is experiencing strong expansion as the prevalence of diabetes continues to rise worldwide. Insulin delivery devices play a crucial role in managing blood ...

Patients with type 2 diabetes who are unable to achieve glycemic control with oral antidiabetic agents require insulin therapy. Insulin is usually administered subcutaneously; however, other delivery ...

The Centers for Disease Control and Prevention (CDC) state that in the last 20 years, the number of adults diagnosed with diabetes has more than doubled. The primary treatment for type 1 diabetes is ...

Diabetes requires an extremely precise form of daily treatment, whereby patients have to inject themselves with several doses of insulin every day, which are suited to their diet and physical activity ...